Analysis of immune regulation and prognosis of chronic hepatitis B virus infection
10.3969/j.issn.1006-2483.2020.06.028
- VernacularTitle:慢性乙肝病毒感染的免疫调节及转归分析
- Author:
Li NA
1
;
Wenjiang ZHAO
1
;
Zhen MA
1
;
Linlin MA
2
Author Information
1. Department of infection, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia 010050, China
2. Department of Pediatrics, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia 010050, China
- Publication Type:Journal Article
- Keywords:
Chronic hepatitis B virus infection;
Immune regulation;
Outcome
- From:
Journal of Public Health and Preventive Medicine
2020;31(6):117-120
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the immune regulation and prognosis of hepatitis B virus (HBV) infection in infected patients, and to analyze the relationship between immune regulation and clinical outcome. Methods The data of 633 cases of HBV infection in Huhhot from January 2015 to December 2018 were retrospectively analyzed. At the same time, healthy people from the Affiliated Hospital of Inner Mongolia Medical University were selected as the control group. Immune cell regulatory factors and lymphocyte subsets in blood of HBV infected and healthy people were tested. The results of one-year clinical outcomes were calculated. The relationship between immune cell regulatory factors and lymphocytes and the clinical outcomes of patients was analyzed by multiple logistics regression. Results The levels of CD4+T cells, CD8+T cells, NK cells, IL-2, and IL-12 in the blood of patients with HBV infection were significantly lower than those in the control group, and decreased as the patients’ clinical outcome deteriorated (P<0.05). The levels of IL-4 and IL-10 in the blood of patients with HBV infection were significantly higher than those in the control group, and increased significantly with the deterioration of the clinical outcome of the patients (P<0.05). There was no significant difference in the levels of INF-γ, B cells and CD4+/CD8+ between the two groups (P>0.05). Low CD4+ T cells, low CD8+ T cells, low NK cells, low IL-2, low IL-12, high IL- 4 and high IL-10 were independent risk factors leading to the deterioration of clinical outcomes (P<0.05). Conclusion The immune regulation of patients with HBV infection is in a state of suppression, which is an independent factor affecting the clinical outcome of patients.
